tirzepatide weight regain study Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Loss Tirzepatide for maintenance of bodyweight
Description
In a comprehensive meta-analysis including 76 RCT and more than 39 thousand participants with type 2 diabetes, treatment with GLP1RAs was associated with a reduction in HbA1c of -0.6% to -2.1% as well as reduction of -10.8 to -57.7 mg/dl in the fasting blood glucose levels relative to placebo [14]
00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
Stopping them does not mean losing progress

Usually resolves within the first month at a stable dose
Your brain turns down the volume

These symptoms can affect school, work, and relationships every day

The resulting pricing disparities between the U.S
